Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Niidae Wiki
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Health care reform
(section)
Page
Discussion
English
Read
Edit
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Germany=== {{Further|Health care in Germany}} Numerous healthcare reforms in Germany were legislative interventions to stabilise the public health insurance since 1983. 9 out of 10 citizens are publicly insured, only 8% privately. [[Health care in Germany]], including its industry and all services, is one of the largest sectors of the [[German economy]]. The total expenditure in [[Health economics (Germany)|health economics of Germany]] was about 287.3 billion euro in 2010, equivalent to 11.6 percent of the gross domestic product (GDP) this year and about 3,510 euro per capita. Direct inpatient and outpatient care equal just about a quarter of the entire expenditure - depending on the perspective.<ref>[[:de:Andreas Goldschmidt|Andreas J. W. Goldschmidt]]: Der 'Markt' Gesundheitswesen. In: M. Beck, A. J. W. Goldschmidt, A. Greulich, M. Kalbitzer, R. Schmidt, G. Thiele (Hrsg.): Management Handbuch DRGs, Hüthig / Economica, Heidelberg, 1. Auflage 2003 ({{ISBN|3-87081-300-8}}): S. C3720/1-24, with 3 revisions / additional deliveries until 2012</ref> Expenditure on [[pharmaceutical drug]]s is almost twice the amount of those for the entire hospital sector. Pharmaceutical drug expenditure grew by an annual average of 4.1% between 2004 and 2010.{{citation needed|date=August 2014}} These developments have caused numerous healthcare reforms since the 1980s. An actual example of 2010 and 2011: First time since 2004 the drug expenditure fell from 30.2 billion euro in 2010, to 29.1 billion Euro in 2011, i. e. minus 1.1 billion Euro or minus 3.6%. That was caused by restructuring the Social Security Code: manufacturer discount 16% instead of 6%, price moratorium, increasing discount contracts, increasing discount by wholesale trade and pharmacies.<ref>[http://www.iges.de/presse07/pressemeldungen_2012/arzneimittel_atlas_2012/index_ger.html B. Häusler, A. Höer, E. Hempel: Arzneimittel-Atlas] {{webarchive|url=https://web.archive.org/web/20130101163421/http://www.iges.de/presse07/pressemeldungen_2012/arzneimittel_atlas_2012/index_ger.html |date=2013-01-01 }} 2012. Springer, Berlin u. a. 2012 ({{ISBN|978-3-642-32586-1}})</ref>
Summary:
Please note that all contributions to Niidae Wiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Encyclopedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Health care reform
(section)
Add topic